Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fourteen Day Safety of Low-Dose Tamoxifen in Patients With Chronic Hepatitis C Who Have Failed Standard Medical Therapy

NCT00749138 is registered in ClinicalTrials.gov with Bader, Ted, M.D. as lead sponsor.

NCT NCT00749138
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00749138 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fourteen Day Safety of Low-Dose Tamoxifen in Patients With Chronic Hepatitis C Who Have Failed Standard Medical Therapy
Lead sponsor
Bader, Ted, M.D.
Phase
Phase 1
Overall status
Completed
Start date
November 30, 2008
Completion date
October 31, 2009
Enrollment
18 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis c